{
    "pmcid": "9132424",
    "qa_pairs": {
        "What is the primary function of the SARS-CoV-2 spike protein as described in the study?": [
            "Facilitating viral entry into host cells through interaction with the ACE2 receptor.",
            "Providing structural support to the viral envelope.",
            "Inhibiting host immune responses during infection.",
            "Replicating viral RNA within host cells."
        ],
        "What was the impact of the core mutations S57G, T103V, and V104W on the VHH72 nanobody?": [
            "They significantly increased affinity for SARS-CoV-2 RBD by enhancing hydrophobic interactions.",
            "They decreased the nanobody's stability in physiological conditions.",
            "They reduced the nanobody's specificity for the SARS-CoV-2 RBD.",
            "They caused the nanobody to lose its ability to bind SARS-CoV-1 RBD."
        ],
        "What was the source of the VHH72 nanobody used in the study?": [
            "Llama immunization with SARS-CoV-1 spike protein.",
            "Mouse immunization with SARS-CoV-2 spike protein.",
            "Human B-cell library screening.",
            "Synthetic phage display library."
        ],
        "Which method was used to screen for enhanced binding clones in the study?": [
            "Yeast surface display (YSD).",
            "Phage display.",
            "Bacterial surface display.",
            "Mammalian cell display."
        ],
        "Which specific region of the SARS-CoV-2 spike protein is highly targeted by neutralizing antibodies but prone to mutations?": [
            "Receptor-binding motif (RBM).",
            "N-terminal domain (NTD).",
            "Fusion peptide (FP).",
            "Heptad repeat 1 (HR1)."
        ]
    }
}